Thyroid Eye Disease
Thyroid Eye Disease (TED) is an autoimmune condition that affects the eyes, often associated with hyperthyroidism. It can cause symptoms such as bulging eyes, swelling, and discomfort.
Thyroid Eye Disease: Batoclimab Extension Study
We are studying the long-term effects of batoclimab in people with Thyroid Eye Disease who previously participated in earlier studies. The goal is to see if it continues to help reduce eye bulging and benefits those who didn't respond to earlier treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you currently planning any corrective surgery or medical therapy for thyroid eye disease (TED)?
- Have you permanently stopped taking the study drug from the previous study?
- In your opinion, do you think the benefits of joining this study would outweigh any risks for you?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Batoclimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Endocrinology
Ledeberg, Belgium
Hopital Erasme
Endocrinology
Negenmanneke, Belgium
Az St-Jan Brugge-Oostende A.V.
Endocrinology
Sint-Andries, Belgium
Sponsor: Immunovant Sciences GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.